Medical Advisory Board
David Badawi, MD
Founder & Chief Technology Officer
Dr. David Badawi is a Founder and Chief Technology Officer of Sight Sciences, Inc. He is a co-inventor of the VISCO360® Viscosurgical System, TRAB®360 Trabeculotomy System, Helix™ Microstent, and TearCare® System.
+ READ MORE
David leads the company’s application and development of technology towards the treatment of the underlying causes of ophthalmic disease. He also oversees the preclinical and clinical development of each of the company’s products.
In addition to building Sight Sciences and helping to bring multiple innovative technologies to the operating room and the ophthalmology clinic, David runs a busy referral and surgical practice in the Chicago suburbs.
David received a BS in Microbiology from the University of Maryland and an MD from Georgetown University. He completed his residency in ophthalmology at the Jules Stein Eye Institute at UCLA and a cornea fellowship at Emory University.
Leon W. Herndon, Jr., MD
Dr. Leon Herndon is a Professor of Ophthalmology with Tenure at Duke University Medical Center and currently serves as Medical Director of the Duke University Eye Center. He is also a member of the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology and is on the editorial board of Glaucoma Today.
+ READ MORE
Dr. Herndon is an Associate Examiner for the American Board of Ophthalmology and has been involved in the Leadership Development Program of the AAO. He has been recognized for his service in the community by receiving the Achievement Award from the AAO and the Dedicated Humanitarian Service Award presented by Dr. Leonel Fernandez Reyna, President of the Dominican Republic, on the occasion of the 2nd Ophthalmology Mission in the Dominican Republic.
Dr. Herndon’s research interests include studying novel treatment approaches in the diagnosis and management of glaucoma. He has ongoing research projects evaluating the high prevalence of primary open angle glaucoma in Ghana, West Africa, where he travels yearly.
John Hovanesian, MD
Dr. John Hovanesian is faculty member at the UCLA Jules Stein Eye Institute, a board-certified ophthalmologist, and an internationally recognized leader in the field of corneal, cataract, refractive, and laser surgery. He has published two eye surgery textbooks—one on the subject of advanced cataract surgery and one on pterygium surgery.
+ READ MORE
Dr. Hovanesian has been invited to lecture to surgeons on five continents, produced numerous surgical teaching videos, and written dozens of articles. He is the chairman of the American Academy of Ophthalmology’s online cataract surgery education committee and an editorial board member for five other eye journals. He has been honored by the American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery for contributions to his field and has been recognized by Wyanoke Publishing as one of the 250 leading innovators in the field of cataract surgery.
Steven Sarkisian, MD
University of Oklahoma
Dr. Steven Sarkisian is the Glaucoma Fellowship Director at the Dean A. McGee Eye Institute and a Professor of Ophthalmology at the University of Oklahoma in Oklahoma City. Dr Sarkisian has an active interest in surgical innovation for the treatment of glaucoma with involvement in numerous clinical trials.
+ READ MORE
He is the Primary Investigator for the Ologen vs. Mitomycin-C study, the Ex-Press vs. trabeculectomy trial (XVT Study), the Ahmed-Baerveldt Comparison Trial (ABC Study) and for pilot studies for the EagleVision glaucoma drainage implants.
Dr. Sarkisian has been a co-investigator on the Trabeculectomy vs. Tube Study (TVT Study), the Primary Trabeculectomy vs. Tube Study (PTVT), and the Anecortave Acetate study. Due to his involvement in the development of new glaucoma technology, he has been active in presenting and publishing his work both in America and internationally. He also was nominated by the American Glaucoma Society to be a consultant to the FDA Ophthalmic Device Panel, where he has served since 2009.
Dr. Sarkisian currently serves on the Editorial Board of Glaucoma Today and is an editorial reviewer for numerous ophthalmology journals. His professional service also includes membership on the glaucoma program committee for both the American Society of Cataract and Refractive Surgery (ASCRS) and the American Academy of Ophthalmology (AAO). He has served as a moderator and speaker at the annual meetings of the ASCRS and the AAO. His responsibilities also include reviewing all wet labs/skills courses, as well as abstracts for poster/paper presentations related to glaucoma for both the ASCRS and AAO.
Robert Stamper, MD
Professor of Clinical Ophthalmology at UCSF
Dr. Robert Stamper has been a Professor of Clinical Ophthalmology and Director of the Glaucoma Service at University of California San Francisco since 1998. For over 30 years, in addition to his glaucoma practice he has written textbooks and taught courses to other ophthalmologists on diagnosing and treating glaucoma.
+ READ MORE
Dr. Stamper belongs to the American Academy of Ophthalmology and received its Lifetime Achievement Award in 2008 for his commitment to excellence in the study and treatment of glaucoma. He also is a member of the American Ophthalmological Society, the American Glaucoma Society and the Association for Research in Vision and Ophthalmology. Currently, he is the immediate past chairman of the Prevent Blindness Northern California. He has also served on the Board of Directors for the Glaucoma Research Foundation since 1987 and is a member of GRF’s Patient Education and Leadership Development Committees.
Dr. Stamper earned his medical degree at State University of NY, Downstate Medical Center. He spent two years as a Peace Corps Physician. Later he completed his residency in ophthalmology and fellowship in glaucoma at Washington University in St. Louis.